Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease. Schwartz GG, Leiter LA, Ballantyne CM, Barter PJ, et al. Diabetes Care 2020 Mar 6. pii: dc19-2204. doi: 10.2337/dc19-2204.

Read + Share

Amedeo Smart

Independent Medical Education

Schwartz GG, Leiter LA, Ballantyne CM, Barter PJ, et al. Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease. Diabetes Care 2020 Mar 6. pii: dc19-2204. doi: 10.2337/dc19-2204.
PMID: 32144166